Recursion Pharmaceuticals (NASDAQ:RXRX) Hits New 52-Week Low at $8.84
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) reached a new 52-week low on Friday . The company traded as low as $8.84 and last traded at $8.85, with a volume of 6427 shares traded. The stock had previously closed at $9.70. RXRX has been the topic of a number of recent analyst reports. […]
Tina Marriott Larson Blake Borgeson Morgan Stanley Securities Exchange Commission Recursion Pharmaceuticals Inc Zacks Investment Research
Source: etfdailynews.com